The expression of pluripotency markers, OCT3/4, NANOG, SOX2, and LIN28A, did not exhibit significant correlation with tumor formation latency and incidence, and the integration of reprogramming factor genes into genome of hiPSCs did not also affect the transcript expression (S3 Fig). The gene discussed is NANOG; the disease is neoplasm.